Table 2 Comparison of clinical and laboratory findings
From: Diagnosis of cutaneous sarcoidosis; clinical and the prognostic significance of skin lesions
| Â | Clinical profile of 72 patients with specific skin involvement (n, %) | Clinical profile of 48 patients with nonspecific skin involvement (n, %) | Statistical significance |
|---|---|---|---|
Respiratory symptoms | 50 (69.4%) | 30 (62.5%) | NS |
Eye involvement | 31 (43.0%) | 17 (35.4%) | NS |
Central nervous system involvement | 7 (9.7%) | 3 (6.2%) | NS |
Abnormal pulmonary function test | 41 (56.9%) | 26 (54.1%) | NS |
Abnormal liver function test | 17 (23.6%) | 10 (20.8%) | NS |
Hypercalcemia | 8 (11.1%) | 5 (10.4%) | NS |
Hypercalciuria | 12 (16.6%) | 7 (14.5%) | NS |
Elevated serum ACE level | 42 (58.3%) | 14 (29.1%) | r = 0.76, p < 0.05 |
BAL lymphocytosis (>28%) | 30 (41.6%) | 11 (22.9%) | r = 0.72, p < 0.01 |
BAL CD4/CD8 ratio (> 3.5) | 28 (38.8%) | 10 (20.8%) | r = 0.70, p < 0.05 |